To dissect the molecular mechanisms governing the effects of IGHG1 on breast cancer cell malignancy, AKT, p-AKT, and VEGF levels were assessed in MCF-7, T47D, MDA-MB-231, and BT-549 BC cell lines. Here, IGHG1 is linked to breast carcinoma.